$2.360
-0.077 (-3.28%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de APVO por análisis de gráficos similares
Alphio's APVO stock price prediction model matches the current Aptevo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.34 (+0.19%). The 1-week path is $2.37 (+1.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Aptevo Therapeutics Inc?
Aptevo Therapeutics is not a good buy right now due to its significantly negative financial performance and poor technical indicators. The current price is $2.37, and the RSI is extremely low at 16.495, indicating oversold conditions. Additionally, the company has a forward P/E of 3.8895, which suggests it is undervalued, but the recent 5-day change of -11.75% and 20-day change of -42.46% indicate a strong downward trend. The main risk is the company's continued negative earnings, with a GAAP EPS of -$87.27 reported, which raises concerns about its financial viability.
APVO cerró en $2.36 el Tuesday, tras bajar -3.28%
Aptevo Therapeutics Inc (APVO) last closed at $2.34, losing -4.10%. These facts feed the 1-day and 1-week APVO price prediction above.
Consenso de analistas
Aptevo Therapeutics Inc (APVO): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Aptevo Therapeutics Inc (APVO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de APVO, ordenadas por similitud.
Análisis de estacionalidad de APVO
Historically the probability of a positive September return for APVO is 0.00%. January offers the highest probability of a positive month at 16.39%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de APVO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $2.89 | $3.03 | $3.58 | +29.38% |
| Oct 2026 | $2.27 | $2.72 | $3.11 | +16.38% |
| Nov 2026 | $2.45 | $2.90 | $2.93 | +23.94% |
| Dec 2026 | $2.54 | $2.81 | $3.29 | +20.04% |
En 2026, se proyecta que Aptevo Therapeutics Inc (APVO) oscile entre $2.27 y $3.58.
Previsión mensual de Aptevo Therapeutics Inc para 2026
En Sep de 2026, se proyecta que Aptevo Therapeutics Inc promedie $3.03, con un mínimo de $2.89 y un máximo de $3.58.
En Oct de 2026, se proyecta que Aptevo Therapeutics Inc promedie $2.72, con un mínimo de $2.27 y un máximo de $3.11.
En Nov de 2026, se proyecta que Aptevo Therapeutics Inc promedie $2.90, con un mínimo de $2.45 y un máximo de $2.93.
En Dec de 2026, se proyecta que Aptevo Therapeutics Inc promedie $2.81, con un mínimo de $2.54 y un máximo de $3.29.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.